Literature DB >> 26289375

Novel imaging approaches in adult asthma and their clinical potential.

Ruth Hartley1, Simonetta Baldi1, Chris Brightling1, Sumit Gupta1,2.   

Abstract

Currently, imaging in asthma is confined to chest radiography and CT. The emergence of new imaging techniques and tremendous improvement of existing imaging methods, primarily due to technological advancement, has completely changed its research and clinical prospects. In research, imaging in asthma is now being employed to provide quantitative assessment of morphology, function and pathogenic processes at the molecular level. The unique ability of imaging for non-invasive, repeated, quantitative, and in vivo assessment of structure and function in asthma could lead to identification of 'imaging biomarkers' with potential as outcome measures in future clinical trials. Emerging imaging techniques and their utility in the research and clinical setting is discussed in this review.

Entities:  

Keywords:  asthma; endobronchial ultrasound; hyperpolarized MRI; molecular imaging; optical coherence tomography; positron emission tomography; quantitative computed tomography

Mesh:

Substances:

Year:  2015        PMID: 26289375     DOI: 10.1586/1744666X.2015.1072049

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  3 in total

Review 1.  Using imaging as a biomarker for asthma.

Authors:  Abhaya Trivedi; Chase Hall; Eric A Hoffman; Jason C Woods; David S Gierada; Mario Castro
Journal:  J Allergy Clin Immunol       Date:  2017-01       Impact factor: 10.793

Review 2.  Quantitative computed tomography imaging of airway remodeling in severe asthma.

Authors:  Philippe A Grenier; Catalin I Fetita; Pierre-Yves Brillet
Journal:  Quant Imaging Med Surg       Date:  2016-02

Review 3.  Pulmonary quantitative CT imaging in focal and diffuse disease: current research and clinical applications.

Authors:  Mario Silva; Gianluca Milanese; Valeria Seletti; Alarico Ariani; Nicola Sverzellati
Journal:  Br J Radiol       Date:  2018-01-12       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.